A test developed by a Madison company to better track cancer DNA in the blood stream will now be covered by Medicare.

The recommended age to start screening for colorectal cancer was lowered in 2021 from 50 to 45 for people of average risk.

A test developed by a Madison company to better track cancer DNA in the blood stream will now be covered by Medicare.  Exact Sciences, which is headquartered in the UW Research Park and has labs along ...

Geneoscopy's journey from a 2015 startup to FDA approval showcases the potential for innovation in colorectal cancer ...

The test claims to analyse epigenomic and genomic data from circulating, cell-free DNA obtained from a simple blood draw.

Oncologists were one of the few provider groups to register support for the FDA rule, reflecting the challenge of assessing ...